| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.03 | 0.9 |